Drugs Made In America Acquisition (DMAA) Change in Accured Expenses (2025)

Drugs Made In America Acquisition (DMAA) reported Change in Accured Expenses of -$80439.0 for Q4 2025, down 151.84% quarter-over-quarter from $155170.0 in Q3 2025.

Drugs Made In America Acquisition (DMAA) Change in Accured Expenses (2025) Analysis & Trends

Drugs Made In America Acquisition has reported Change in Accured Expenses for 1 years, with the latest figure at -$80439.0 in Q4 2025.

  • For the quarter ending Q4 2025, Change in Accured Expenses changed N/A year-over-year to -$80439.0; the trailing twelve-month figure through Dec 2025 stood at $144904.0 (changed N/A YoY), and the FY2025 full-year result was $144904.0, up 87.51% from the prior year.
  • Change in Accured Expenses for Q4 2025 stood at -$80439.0, down from $155170.0 in the prior quarter.
  • The five-year high for Change in Accured Expenses was $155170.0 in Q3 2025, with the low at -$80439.0 in Q4 2025.

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Change in Accured Expenses (Qtr)
1 EQV Ventures Acquisition 477.69 Mn 477.69 Mn - 112,542.00
2 Berto Acquisition 312.46 Mn 312.46 Mn - 82,500.00
3 Centurion Acquisition 311.65 Mn 311.65 Mn - 95,385.00
4 GP-Act III Acquisition 311.36 Mn 311.36 Mn - 22,036.00
5 Churchill Capital Corp IX 310.79 Mn 310.79 Mn - 772,181.00
6 WEN Acquisition 309.15 Mn 309.15 Mn - -13,704.00
7 Bold Eagle Acquisition 275.54 Mn 275.54 Mn - 46,445.00
8 Soulpower Acquisition 264.91 Mn 264.91 Mn - 437,800.00
9 BTC Development 262.16 Mn 262.16 Mn - 28,266.00
10 Drugs Made In America Acquisition 223.11 Mn 223.11 Mn - -80,439.00

Historic Data

Download Data
DateValue
Dec 31, 2025 -80,439.00
Dec 31, 2025 -80,439.00
Sep 30, 2025 155,170.00
Sep 30, 2025 155,170.00
Jun 30, 2025 14,970.00
Jun 30, 2025 14,970.00
Mar 31, 2025 55,203.00
Mar 31, 2025 55,203.00